关注
T Ciulla, TA Ciulla, Thomas Ciulla
T Ciulla, TA Ciulla, Thomas Ciulla
Chief Medical Officer, Viridian; Volunteer Clinical Professor, Indiana Univ Schl of Medicine
在 midwesteye.com 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results
DF Martin, MG Maguire, SL Fine, G Ying, GJ Jaffe, JE Grunwald, C Toth, ...
Ophthalmology 119 (7), 1388-1398, 2012
19902012
Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study
DM Brown, M Michels, PK Kaiser, JS Heier, JP Sy, T Ianchulev
Ophthalmology 116 (1), 57-65. e5, 2009
17412009
Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies
TA Ciulla, AG Amador, B Zinman
Diabetes care 26 (9), 2653-2664, 2003
12292003
Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study
PA Campochiaro, JS Heier, L Feiner, S Gray, N Saroj, AC Rundle, ...
Ophthalmology 117 (6), 1102-1112. e1, 2010
12122010
Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study
DM Brown, PA Campochiaro, RP Singh, Z Li, S Gray, N Saroj, AC Rundle, ...
Ophthalmology 117 (6), 1124-1133. e1, 2010
10942010
Vascular endothelial growth factor–induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective β-isoform–selective inhibitor
LP Aiello, SE Bursell, A Clermont, E Duh, H Ishii, C Takagi, F Mori, ...
Diabetes 46 (9), 1473-1480, 1997
9411997
Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study
QD Nguyen, SM Shah, AA Khwaja, R Channa, E Hatef, DV Do, D Boyer, ...
Ophthalmology 117 (11), 2146-2151, 2010
7742010
Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update
TA Ciulla, MB Starr, S Masket
Ophthalmology 109 (1), 13-24, 2002
7332002
Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes
P Stalmans, MS Benz, A Gandorfer, A Kampik, A Girach, S Pakola, ...
New England Journal of Medicine 367 (7), 606-615, 2012
7202012
A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch …
IU Scott, MS Ip, PC VanVeldhuisen, NL Oden, BA Blodi, M Fisher, ...
Archives of ophthalmology 127 (9), 1115, 2009
7002009
A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central …
MS Ip, IU Scott, PC VanVeldhuisen, NL Oden, BA Blodi, M Fisher, ...
Archives of ophthalmology 127 (9), 1101, 2009
6772009
Intravitreal triamcinolone acetonide in exudative age-related macular degeneration
RP Danis, TA Ciulla, LM Pratt, W Anliker
Retina 20 (3), 244-250, 2000
6512000
Ranibizumab and bevacizumab for neovascular age-related macular degeneration
CATT Research Group
New England Journal of Medicine 364 (20), 1897-1908, 2011
6242011
Twelve-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration
BG Busbee, AC Ho, DM Brown, JS Heier, IJ Suñer, Z Li, RG Rubio, P Lai, ...
Ophthalmology 120 (5), 1046-1056, 2013
5962013
Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study
JS Heier, AN Antoszyk, PR Pavan, SR Leff, PJ Rosenfeld, TA Ciulla, ...
Ophthalmology 113 (4), 633-642. e4, 2006
5282006
Primary end point (six months) results of the ranibizumab for edema of the macula in diabetes (READ-2) study
QD Nguyen, SM Shah, JS Heier, DV Do, J Lim, D Boyer, P Abraham, ...
Ophthalmology 116 (11), 2175-2181. e1, 2009
5002009
Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema
PA Campochiaro, DM Brown, A Pearson, T Ciulla, D Boyer, FG Holz, ...
Ophthalmology 118 (4), 626-635. e2, 2011
4842011
Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study
JS Heier, DS Boyer, TA Ciulla, PJ Ferrone, JM Jumper, RC Gentile, ...
Archives of Ophthalmology 124 (11), 1532-1542, 2006
3962006
A susceptibility locus for multiple sclerosis is linked to the T cell receptor β chain complex
E Seboun, MA Robinson, TH Doolittle, TA Ciulla, TJ Kindt, SL Hauser
Cell 57 (7), 1095-1100, 1989
2911989
Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials
GJ Jaffe, DF Martin, CA Toth, E Daniel, MG Maguire, GS Ying, ...
Ophthalmology 120 (9), 1860-1870, 2013
2852013
系统目前无法执行此操作,请稍后再试。
文章 1–20